Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern
Abstract
BackgroundMyelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is the most common inflammatory demyelinating disease in children, yet few studies have examined health-related quality of life (HRQOL) in this population. This study aimed to compare HRQOL between children with MOGAD and healthy controls, and to identify risk factors for impaired HRQOL.MethodsIn this retrospective, single-center case-control study, children with MOGAD (147 patients) and healthy controls (150 subjects) were enrolled. HRQOL was assessed using the PedsQL™ 4.0 and dichotomized into high-score (76 patients) and low-score groups (71 patients). Univariate and multivariable logistic regression analyses were performed to identify risk factors for low HRQOL, with subgroup analyses stratified by relapse frequency.ResultsOf 203 pediatric patients screened, 147 were enrolled (79 female, 53.7%); median age at onset was 6.0 (4.0–9.0) years, with a mean follow-up of 44.8 ± 12.4 months. Children with MOGAD had significantly lower HRQOL scores than healthy controls (P < 0.001). Age at onset (OR = 1.238; 95%CI=1.086-1.411; P = 0.001), relapsing course (OR = 4.345; 95%CI =2.017-9.359; P = 0.014), and optic neuritis as the first acute phenotype (OR = 3.895, 95%CI=1.485-10.216; P = 0.046) were independently associated with an increased risk of low HRQOL scores. Further subgroup analysis stratified by relapse frequency revealed that patients experiencing a second attack had a significantly higher risk of low HRQOL than those with other relapse frequencies (OR = 3.794; 95%CI=1.388-8.371; P = 0.009). Cox regression and Kaplan–Meier survival analyses further demonstrated that, compared with the high-HRQOL group, the low-HRQOL group had a significantly shorter time to relapse and a higher relapse rate (HR = 3.46; 95% CI = 1.93–6.18; P < 0.001).ConclusionHRQOL is significantly impaired in children with MOGAD compared with healthy age-matched controls. Age at onset, optic neuritis as the initial phenotype, and disease relapse were independent risk factors for low HRQOL. The second attack was significantly associated with a higher risk of low HRQOL. Targeting the second attack may therefore offer a key window for intensified psychosocial and rehabilitative interventions. Prospective studies are warranted to validate these findings and inform strategies to preserve long-term quality of life in this population.
Related
- Quality deterioration characteristics and metabolomic analysis of nano-packaged Venus Golden apples under dynamic temperature fluctuations
- NOTCH2 VUS Interpretation in Pediatric Cholestasis: A 365-Variant Landscape and Genotype–Phenotype Analysis of 7 Cases
- Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.
- Testing Association between Candidate-Gene Markers and Phenotype in Related Individuals, by Use of Estimating Equations
- Pangenome Graph Node-Phenotype Association shows GWAS-like quality results with only few individuals
BibTeX
@article{wang2026healthrelated,
title = {{Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern}},
author = {Xin Wang and Ruibin Zhao and Yi Qu and Chong Liu and Kang Liu and Fang Chen and Pengqian Zhang and Qing Zhao and Huixiao Zheng and Yu Zhang and Xiaofei Zhang and Li Guo and Baoguang Li},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.2017057},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2017057},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Health-related quality of life deterioration in pediatric MOGAD patients: role of age at onset, phenotype and relapse pattern
AU - Xin Wang
AU - Ruibin Zhao
AU - Yi Qu
AU - Chong Liu
AU - Kang Liu
AU - Fang Chen
AU - Pengqian Zhang
AU - Qing Zhao
AU - Huixiao Zheng
AU - Yu Zhang
AU - Xiaofei Zhang
AU - Li Guo
AU - Baoguang Li
PY - 2026
DA - 2026/11/16
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2017057
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2017057
AB - BackgroundMyelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is the most common inflammatory demyelinating disease in children, yet few studies have examined health-related quality of life (HRQOL) in this population. This study aimed to compare HRQOL between children with MOGAD and healthy controls, and to identify risk factors for impaired HRQOL.MethodsIn this retrospective, single-center case-control study, children with MOGAD (147 patients) and healthy controls (150 subjects) were enrolled. HRQOL was assessed using the PedsQL™ 4.0 and dichotomized into high-score (76 patients) and low-score groups (71 patients). Univariate and multivariable logistic regression analyses were performed to identify risk factors for low HRQOL, with subgroup analyses stratified by relapse frequency.ResultsOf 203 pediatric patients screened, 147 were enrolled (79 female, 53.7%); median age at onset was 6.0 (4.0–9.0) years, with a mean follow-up of 44.8 ± 12.4 months. Children with MOGAD had significantly lower HRQOL scores than healthy controls (P < 0.001). Age at onset (OR = 1.238; 95%CI=1.086-1.411; P = 0.001), relapsing course (OR = 4.345; 95%CI =2.017-9.359; P = 0.014), and optic neuritis as the first acute phenotype (OR = 3.895, 95%CI=1.485-10.216; P = 0.046) were independently associated with an increased risk of low HRQOL scores. Further subgroup analysis stratified by relapse frequency revealed that patients experiencing a second attack had a significantly higher risk of low HRQOL than those with other relapse frequencies (OR = 3.794; 95%CI=1.388-8.371; P = 0.009). Cox regression and Kaplan–Meier survival analyses further demonstrated that, compared with the high-HRQOL group, the low-HRQOL group had a significantly shorter time to relapse and a higher relapse rate (HR = 3.46; 95% CI = 1.93–6.18; P < 0.001).ConclusionHRQOL is significantly impaired in children with MOGAD compared with healthy age-matched controls. Age at onset, optic neuritis as the initial phenotype, and disease relapse were independent risk factors for low HRQOL. The second attack was significantly associated with a higher risk of low HRQOL. Targeting the second attack may therefore offer a key window for intensified psychosocial and rehabilitative interventions. Prospective studies are warranted to validate these findings and inform strategies to preserve long-term quality of life in this population.
SN - 1664-3224
ER -